Lee, J.; Um, W.; Moon, H.; Joo, H.; Song, Y.; Park, M.; Yoon, B.; Kim, H.-R.; Park, J.H.
Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound. Pharmaceutics 2022, 14, 2603.
https://doi.org/10.3390/pharmaceutics14122603
AMA Style
Lee J, Um W, Moon H, Joo H, Song Y, Park M, Yoon B, Kim H-R, Park JH.
Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound. Pharmaceutics. 2022; 14(12):2603.
https://doi.org/10.3390/pharmaceutics14122603
Chicago/Turabian Style
Lee, Jeongjin, Wooram Um, Hyungwon Moon, Hyeyeon Joo, Yeari Song, Minsung Park, Been Yoon, Hyun-Ryoung Kim, and Jae Hyung Park.
2022. "Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound" Pharmaceutics 14, no. 12: 2603.
https://doi.org/10.3390/pharmaceutics14122603
APA Style
Lee, J., Um, W., Moon, H., Joo, H., Song, Y., Park, M., Yoon, B., Kim, H.-R., & Park, J. H.
(2022). Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound. Pharmaceutics, 14(12), 2603.
https://doi.org/10.3390/pharmaceutics14122603